Organ Injury Biomarkers in Newly Diagnosed Type 1 Diabetes
Part of Hormones & metabolism, Immune system & allergy, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at signs of acute organ injury in children newly diagnosed with type 1 diabetes. It aims to understand how the body reacts to diabetes and its treatment, which could help improve care for kids like yours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 and 16 years old.
- Your child has been newly diagnosed with type 1 diabetes.
- Your child is in the hospital for their first diabetes evaluation and treatment.
- Your child may or may not have diabetic ketoacidosis (a serious complication of diabetes).
- Your child has no other known chronic kidney or heart disease, or active infections unrelated to diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children age 1 to 16 who are in the hospital for diabetic ketoacidosis (DKA). It aims to understand how these children are doing and what treatments might work best.
This study looks at blood protein patterns in children with type 1 diabetes to better understand the condition. It may help researchers find markers linked to how diabetes is doing, especially in young, early-stage children.
This trial is looking for children with newly diagnosed type 1 diabetes to study how to detect the condition earlier. It focuses on kids who have already reached the stage where symptoms appear, to improve understanding of the disease.
This study looks at how blood vessels and blood pressure change in children soon after being diagnosed with type 1 diabetes. It may help doctors better understand early vascular risk and how to monitor it.
This study is looking at different kidney health patterns in people with diabetes, especially diabetic kidney disease and people who have not developed kidney damage despite long-term diabetes. It may help researchers understand why kidney problems happen—and what protective factors might prevent them.
This study measures “circulating biomarkers” (blood-based signals) in people with type 1 or type 2 diabetes, and in some people without diabetes who test positive for certain diabetes antibodies. The goal is to understand what these blood signals can tell us about diabetes development and progression.
Hear when a new Diabetic Ketoacidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.